Skip to main content
Veterinary Medicines

Selevitan vet. 50 mg/ml + 0,6 mg/ml injektioneste, liuos

Authorised
  • ALPHATOCOPHEROL ACETATE
  • Sodium selenite

Product identification

Medicine name:
Selevitan vet. 50 mg/ml + 0,6 mg/ml injektioneste, liuos
Active substance:
  • ALPHATOCOPHEROL ACETATE
  • Sodium selenite
Target species:
  • Cattle
  • Sheep
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • ALPHATOCOPHEROL ACETATE
    50.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Sodium selenite
    0.60
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Sheep
      • Meat and offal
        0
        day
    • Pig
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA12CE99
Authorisation status:
  • Valid
Authorised in:
  • Finland
Available in:
  • Finland
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Pharmaxim AB
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bela-Pharm GmbH & Co. KG
Responsible authority:
  • Finnish Medicines Agency
Authorisation number:
  • 8865
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Finnish (PDF)
Published on: 20/02/2024

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Finnish (PDF)
Published on: 14/11/2023
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."